Drug-maker Endo signs $65M opioid settlement with Florida
(Reuters) — Drugmaker Endo International PLC said Tuesday it had agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the drug-maker helped fuel the U.S. opioid epidemic.
The deal is the latest in a string of settlements that Endo has struck in recent months to resolve similar cases, including a $63 million settlement with Texas in December.
The Florida settlement included no admission of wrongdoing, Endo said, while reiterating that its goal was to achieve a global opioid settlement.
Thousands of lawsuits have been filed seeking to hold drug-makers, drug distributors and pharmacy chains responsible for a drug abuse crisis, which the U.S. government says has led to hundreds of thousands of overdose deaths over two decades.
Endo shares rose nearly 4% to $3.40 in premarket trading.
Read Next
-
Drugmaker Endo settles opioid claims by N.Y., counties for $50M
(Reuters) – Drugmaker Endo International PLC on Thursday said it has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and marketing of opioids.
Related Stories
-
Drugmaker Endo settles opioid claims by N.Y., counties for $50M
-
Drug-maker Endo reaches $63 million opioid settlement with Texas
Most Read in Risk Management
-
2. Zurich North America names professional liability, cyber leader
-
6. Aon reports 5% revenue increase; looks to middle-market growth
